Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes

12. november 2026 opdateret af: The Collagen Co. - GLP-1 Users

This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².

All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • Nevada
      • Las Vegas, Nevada, Forenede Stater, 89101
        • Citruslabs

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 55 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Adults aged 18-55 years at the time of enrollment.
  • BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
  • Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
  • Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
  • Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
  • In good general health.
  • Resides in the United States.

Exclusion Criteria:

  • Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
  • Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
  • Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
  • Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
  • Currently testing, or plan to in the next 6 weeks, a product for another research study.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Glow Shakes Premium Collagen Meal Replacement Arm

All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Body Weight
Tidsramme: Baseline to Week 6

Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

Baseline to Week 6
Change in Body Fat Percentage
Tidsramme: Baseline to Week 6

Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

Baseline to Week 6

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Self-Reported Weight Management Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Hunger Intensity
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Satiety Duration
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Food Craving Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced)

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Skin Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Hair Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Nail Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Participant-Reported Product Satisfaction
Tidsramme: Week 6

Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire

Week 6
Participant-Reported Product Tolerability
Tidsramme: Week 6

Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire

Week 6
Participant-Reported Overall Product Experience
Tidsramme: Week 6

Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire

Week 6

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Samarbejdspartnere

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. november 2026

Primær færdiggørelse (Anslået)

1. februar 2027

Studieafslutning (Anslået)

1. februar 2027

Datoer for studieregistrering

Først indsendt

12. november 2026

Først indsendt, der opfyldte QC-kriterier

12. november 2026

Først opslået (Faktiske)

18. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

12. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • THECO-22384

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .